Role of endothelin in the pathophysiology of renal ischemia-reperfusion in normal rabbits. The present study addressed the acute effects of endothelin-1 on renal function and neutrophils accumulation in the setting of in vivo severe (60 mm) acute ischemia/reperfusion. Ischemia/reperfusion decreased renal functional parameters and increased renal neutrophil accumulation and medullary congestion. All these parameters markedly improved with the intrarenal administration of anti-endothelin-1 antiserum. Comparatively, the intrarenal infusion of endothelin-1 decreased renal function and increased neutrophil accumulation. Abnormalities in renal histology were, however, less pronounced than with ischemia/ reperfusion. In experiments using rabbit isolated perfused kidneys, endothelin-1 induced the accumulation of labeled neutrophils. This accumulation was similar to that observed in kidneys obtained after 60 minutes of ischemia plus 60 minutes of reperfusion. Both endothelin and ischemia/ reperfusion effects were counteracted by an anti-endothelin antibody. In further in vitro studies, we found that endothelin-1-induced the expression of the CD18 antigens on the neutrophil surface. In subsequent experiments based on this effect of ET-1 on CD18 antigens, a blockade of both ischemia/reperfusion-induced and endothelin-1-induced neutrophil accumulation was obtained by infusion an anti-CD18 antibody. In conclusion, our experiments disclosed the critical role of endothelin-l as a major promoter of early neutrophil accumulation after ischemia/reperfusion, which occurred through an integrin-mediated mechanism. from our and other laboratories amply supports the existence of a relevant role of ET-1 in renal ischemia [10] [11] [12] [13] [14] .
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from our and other laboratories amply supports the existence of a relevant role of ET-1 in renal ischemia [10] [11] [12] [13] [14] .
In the past two years, several effects of ET-1-related mechanisms have been described as neutrophil properties, namely, Ca2 mobilization [15] , nitric oxide (NO) and O2 production [16, 17] , adhesion to endothelial cells and heart tissue [18] , aggregation [19] and neutrophil-dependent platelet activation [20] . However, data are needed examining the effects of ET-1 on neutrophils in pathological circumstances. In the case of ischemic injury, increased ET-1 formation and neutrophils accumulation are coexistent phenomena [21, 22] , and the presence of a mechanistic relationship between them is worthy of exploration.
The aim of the present experiments was to test the hypothesis that ET-l has a relevant role on hR-related renal neutrophil accumulation. The complementary hypothesis, that the effects of kidney-borne ET-1 may extend to the systemic level, also was tested by examining neutrophil accumulation in the hearts of animals with kidney hR or intrarenal ET-1 infusion.
Methods
In vivo studies Ischemia/reperfusion (I!R) is a leading cause of organ damage in diverse clinical circumstances [reviewed in [1] [2] [3] . The mechanisms proposed to explain the hR-induced damage include anoxia, neutrophil accumulation and release of oxygen free radicals during reperfusion and lytic enzymes [13] . Several approaches have been tried, such as: to restore blood flow by using vasodilatory drugs [4] ; to reduce the effects of oxygen free radicals by means of scavenging agents [5, 61; and to diminish neutrophil accumulation or block the activation of neutrophil-borne, tissuedamaging enzymes, by using antibodies against adhesive integrins or protease inhibitors [7, 8] .
In recent years, considerable information has been gathered on the role of the vasoconstricting peptide, endothelin-1 (ET-1), in circulatory regulation [reviewed in 9]. Experimental evidence body temperature was monitorized by an intrarectal electrical thermometer (Elektrolaboratoriet, Copenhagen, Denmark) and maintained between 36° and 37°C to avoid possible interference in the ischemic phenomenon by temperature changes [23] . At the end of a 45-minute equilibration period, blood samples were taken for the determination of packed cell volume, creatinine and electrolytes. Thereafter, the left renal artery was occluded for 60 minutes with a nontraumatic clamp, as described previously [10] . At the end of this time, the clamp was released and reperfusion allowed for an additional 60 minutes. Once the reperfusion phase was finished, samples for ET-1 measurement were obtained from renal and femoral veins, the animals were killed by overdose of anesthesia, and the kidney and heart were extracted, washed with cold PSS and frozen in liquid nitrogen.
Measurement of renal function. Renal functional parameters were measured as previously described [10, 24] [25] and classified using a numerical score to define the degree of tubular damage: 0 = no damage; 1 = unicellular, patchy isolated necrosis; 2 = tubular necrosis less than 25%; 3 = tubular necrosis between 25 and 50%; 4 more than 50% tubular necrosis and presence of infarcted tissue. Degree of medullary congestion was defined by: 0 = no congestion; 1 = vascular congestion with identification of erythrocytes by x400 magnification; 2 = vascular congestion with identification of erythrocytes by x200 magnification; 3 = vascular congestion with identification of erythrocytes by X 100 magnification; 4 = vascular congestion with identification of erythrocytes by X40 magnification. Measurement of myeloperoxidase activity. MPO activity was measured in animals submitted to hRwith or without the different maneuvers detailed in the experimental protocols (see below), by assessing the change in absorbance of o-dianisidine hydrochloride, as described [18, 26] , and after homogenizing the tissues in 50 m potassium phosphate buffer, pH 6.0, containing 0.5% hexadecyltrimethylammonium bromide. In the conditions used, no interference could be expected from peroxidase activities other than MPO [26] . A standard in vitro curve was constructed using known numbers of neutrophils that showed a significant correlation between the number of neutrophils and MPO activity (r = 0.92, P < 0.001).
Measurements of plasma ET-1 levels. Blood samples were extracted in cold tubes containing EDTA (0.2 M), phenyl-methylsulphonyl fluoride (10 M) and leupeptin (10 tg/ml), centrifuged (3000 rpm, at 4°C for iS mm) and plasma stored at -70°C until determinations were performed. ET-1 levels were measured by enzymoimmunoassay (EIA; Cayman Chemical, MI, USA). The sensitivity of the assay was 7.8 pg/mi and the intra-and interassay variations were below 5.0 and 15%, respectively.
Experimental protocols for the in vivo studies. All of the solutions were freshly prepared in sterile PSS (37°C, pH 7.4), immediately before using. The different agents or vehicle were given as detailed below, by continuous intrarenal infusion (3.75 mi/hr) through the retrograde cannulated branch of the renal artery. All the infusions began immediately prior (2 mm) to the initiation of reperfusion and lasted during the entire reperfusion phase. In the animals receiving no pharmacological agents, a similar volume of the vehicle was administered.
The rabbits were assigned to one of the following protocols.
Study I: (a) hR group. A group of animals (N = 10) was submitted to hR as detailed above, receiving only vehicle infu- that had no cross reactivity with any of the endothelin isoforms was used for control purposes.
(d) Dopamine group. Dopamine, a non-NO-mediated vasodilator, was used at renal vasodilating dose (2 jtg/kg body wt/min, N = 3) to assess whether any effect of the maneuvers mentioned above could be unspecifically attributed to vasodilation. In previous set-up experiments, we found that in control animals, this dose of dopamine increased CIN and CPAFI by 30 2 (P < 0.01) and 47 3% (P < 0.005), respectively (Cernadas et al, unpublished results).
Study II. To further clarify the role of ET-1 on the pathophysiological mechanisms involved in I/R, the response to 60 minutes of intrarenal ET-1 infusion (0.027 jtg/min, N = 7) was examined.
In this case, the kidneys were not submitted to renal artery clamping and the ET-1 infusion period substituted for the renal The monoclonal antibodies anti-CD18 MoAb (TSI/18) and P3X63 used in the in vitro studies described below were provided by Prof. F. Sanchez Madrid (Hospital de Ia Princesa, Universidad Autónoma, Madrid, Spain) and prepared as reported [29] . P3X63 myeloma culture supernatant was used as a negative control. No in vivo studies could be done using the TS 1/18 MoAb because of its limited availability.
Flow cytometly experiments. In an effort to clarify whether the effects of ET-1 on neutrophil accumulation were related to changes in the surface expression of adhesive integrins. For this purpose, rabbit neutrophils were incubated with ET-1 (10-v M) for 30 minutes. After the incubation was completed, the neutrophils were incubated with the anti-CD 18 MoAb followed by a second incubation with a fluorescein isothyocyanate-conjugated goat anti-mouse IgG (The Binding Site, Birmingham, UK). The fluorescence was measured as described [18] by using an EPICS flow cytometer/sorter (Coulter) at 480 nm excitation and 520 nm emission. A minimum of 5000 cells were analyzed for each sample. The data were displayed as one-parameter histograms plotting the logarithm of the fluorescence signal versus the cell number.
Isolated perfused kidney experiments. Experiments on isolated perfused kidneys were done as an in vitro probe for neutrophil accumulation in renal tissue. Perfusion of isolated rabbit kidneys was carried out according to modifications of the methods of Maack [30] and Little and Cohen [31] . Briefly, after a surgical preparation procedure similar to described above, the left kidney was perfused in situ (PSS infusion, 4°C, arterial 22-gauge needle) and rapidly removed and placed into a siliconyzed glass beaker (37°C, 95% 02, 5% C02) which contained Krebs-Henseleit solution (pH 7.4) supplemented with 5 m glucose, 5% fatty-acid free bovine serum albumin and 10 mI/liter of a 20 amino acid mixture (NitrOgeno 10; Ibys, Madrid, Spain). Flow was initially set at 10 ml/min and graduated to keep pressure at 100 mm Hg. A peristaltic pump (Harvard) was used for carrying out the perfusion; the perfusion system was closed, therefore allowing the perfusate to recirculate. Experiments were performed as follows: (a) in kidneys from normal animals, ET-1 (0.013 JIg/mm in Krebs-Henseleit solution, N = 4) or vehicle (N = 4) were perfused for 30 minutes at a rate of 0.1 mi/mm. The ET-i dose was selected according to previous reports, which have shown that doses in the above-mentioned range did not produce significant in vivo vasoconstrictor effects [32] . Two minutes after the beginning of the ET-1 infusion, 51Cr-labeled rabbit neutrophils in sterile Krebs buffer (8 x 106 in 0.5 ml, 79,995 10,354 cpm/8 >< 10' cells) were injected as a bolus. The experiments were stopped by washing out the non adherent neutrophiis with fresh KrebsHenseleit buffer, the kidneys were homogenized in 10% TCA and radioactivity counted. Abbreviations are: ET-1, endothelin-1; I/R, 60 mm ischemia/60 mm reperfusion. A mean vlaue of all the animals was used for the baseline data represented in this table. This was done because no significant differences in the baseline CIN or CPAH were detected between the different groups in the baseline measurements, P = NS, data not shown).
Significant differences with respect to the baseline 6 Significant differences with respect to ischemia alone ET-1 in the functional behavior of the isolated perfused kidney preparation.
To discard a nonspecific trapping of neutrophils induced by a putative undetected vasoconstrictor effect of ET-1, two additional experiments were carried out: (a) neutrophils were incubated with the MoAb against the CD18 antigen, TSI/18, from 10 minutes before and throughout their infusion in the renal circulation. (b) To rule out any possible nonspecific interaction between antihuman TS1/18 and rabbit neutrophils, experiments were carried out using human neutrophils preincubated with TS1/18 before infusing them into the isolated rabbit kidney (N = 3). Human neutrophils were prepared and labeled following the same procedure than for rabbit neutrophils.
Additional experiments were done to determine the role of Values are expressed as mean SEM, after 60 mm ischemia/60 mm reperfusion (N = 10) or in the presence of anti-ET-1 antibody (1:10000, N 6) or nonspecific IgG (N = 3). Abbreviations are: UV, urinary volume; UNaV, urinary sodium excretion; FENU, fractional sodium excretion; I/R, 60 mm ischemia/60 mm reperfusion.
Significant differences (P < 0.001) with respect to the baseline ' Significant differences (P < 0.05) with respect to JR alone baseline; Table 2 ). A recovery to near baseline values (Table 1, P < 0.001) of the post-hR decrease in CIN and CPAH was obtained with the infusion of the anti-ET-1 antibody (1:10000). The anti-ET-1 antibody infusion also induced significant changes on diuresis, natriuresis and FEN with respect to l/R alone ( Table 2) . No effects on CIN, CPAH, urinary volume or Na excretion were detected with the administration of the nonspecific antibody (P = NS; Table 1) . The experiments using dopamine demonstrated only a minor effect on CIN (0.79 0.18 mI/mm, P = NS with respect to hR alone) and a moderate effect on CPAI{ (2.64 0.94 mI/mm, P < 0.05 with respect to hR alone), UV (50.9 5.4 j.d/min, P < 0.05 with respect to hR alone) and UNUV (9.9 1.8 j.tEq/min, P < 0.02 with respect to hR alone). The FENa was, however, in a range similar to that in h/R (8.9 0.9%, P = NS). No major changes in systemic mean arterial pressure were observed with either of the experimental maneuvers (P = NS; data not shown).
(b) Histology studies. I/R provoked a significant degree of medullary congestion and tubular damage, which was significantly improved by the infusion of the ET-1 antibody and not by the nonspecific IgG (Fig. 1) . Histologic scores at baseline are not represented, since they were not different from zero. No significant increase in neutrophil accumulation was found at optical microscopy with any of the experimental maneuvers (P = NS for all the samples with respect to the nonischemic controls, data not shown). In view of the MPO findings shown in the next paragraph, multiple samples from differents areas of the kidney were used to further ascertain the reliability of this observation.
(c) Measurement of myeloperoxidase activity. An increased renal MPO activity, a marker of neutrophil accumulation, was observed after hR (Fig. 2) . This increase was blunted by the administration of the anti-ET-1 antibody infusion (1:10000; Fig. 2 ). An increased MPO activity was also detected in the hearts of the animals with renal l/R (Fig. 2) . Moreover, no effect on the increased MPO activity was observed in the animals submitted to hR infused with dopamine (2 jig/kg body wt/min, N = 3; MPO, 2.4 0.4 vs. 2.1 0.2 U!g tissue in hR and hR + dopamine, respectively; P = NS).
This phenomenon was also inhibited in the presence of the anti-ET-1 antibody infusion (1:10000; Fig. 2) . No significant effects were detected with the administration of nonspecific IgG (1:10000; Fig. 2) .
Moreover, no effect on the increased MPO activity was detected in the animals submitted to hR and infused with dopamine (2 jig/kg body wt/min, N = 3; MPO, 2.4 0.4 vs. 2.1 0.2 UIg tissue in hR and I/R + dopamine, respectively; P NS).
No changes in baseline MPO activity were observed in either Kidney Heart in the renal vein were in the limit of detection in control conditions (9.3 1.2 pg/ml), hut increased significantly after hR in vehicle-treated rabbits (48.2 6.8 pg/mI, P < 0.01 with respect to the baseline). Also, a similar increase was detected in systemic venous blood (baseline 7.9 1.5; hR 45.7 4.7 pg/mI, P < 0.01). No differences were observed in renal vein ET-1 between vehicleand anti-ET-1 antibody-treated animals (42.2 7.5 pg/mI).
Study II Renal functional studies. The intrarenal ET-.1 infusion caused a significant reduction of CIN and CpAI (Table 3) , which was blocked by the anti-ET-1 antibody (Table 3) . Also, a reduction in urinary volume and Na excretion was observed, with increased FENa (Table 4) . No changes in systemic arterial pressure were detected with the administered dose (0.027 ,iLg/min) of ET-1 (increase in mean arterial pressure 4 1.8 mm Hg, P = NS).
Renal histology. In spite of the intense functional changes observed after ET-1 infusion, only a moderate degree (1.9 0.4 histologic score, N = 4, P < 0.02 with respect to the control animals) of medullary congestion was detected. No signs of tubular damage were detected in any instance (score NS with respect to control).
Measurement of myeloperoxiduse activity. The intrarenal administration of ET-1 significantly increased MPO activity within the rabbit kidney (Fig. 3) . A significant increase of MPO activity in the rabbit heart was also detected in these conditions (Fig. 3) .
In vitro experiments
Study IV Flow cytometly studies. The flow cytometry experiments showed a 34.7 3.6% increase in CD18 expression in ET-1 (10-v M)-treated with respect to untreated neutrophils (Fig. 4) .
Neutrophil accumulation in the isolated, perfused kidney. ET-1 infusion markedly increased the accumulation of rabbit neutrophils on the isolated, perfused rabbit kidney (neutrophil accumulation with vehicle infusion, 1.5 X 106 1.6 x i0; with ET-1 infusion, 4. Relative fluorescence intensity, log neutrophil accumulation by 75 15% (P < 0.01), whereas only 1.2 0.8 inhibition was obtained by preincubating the neutrophils with the non specific MoAb P3 >< 63 (P = NS).
ET-l stimulated human neutrophil accumulation in a similar degree than observed with rabbit neutrophils (increase of human neutrophils accumulation 3.01 x 106 3.01 X 1O neutrophils, N 4, P < 0.05). This effect was inhibited (73 12% inhibition, N = 3, P < 0.05 with respect to ET-1 alone) by the simultaneous infusion of TS1/18.
An increased accumulation of 51Cr-labeled neutrophils was also observed in isolated, perfused kidneys extracted after one hour of in vivo ischemia, followed by one hour reperfusion (% accumulation 55. 5.8% reduction, P < 0.01 with respect to the control, non-hR kidneys). This effect was markedly blocked in the presence of the anti-FT-I antibody (16.4 5.6% reduction, P = NS with respect to the control, P < 0.01 with respect to the hR + nonspecific IgG). The mean value of C1 in the control, non-hR kidneys was 367
37 .d min g1 wet kidney weight.
Moreover, different characteristics of intrarenal resistances were observed in the hR kidneys compared to the hR kidneys perfused with anti-ET-1 antibody and control kidneys, namely, the mean flow necessary for maintaining 100 mm Hg intrarenal pressure throughout the 60-minute perfusion period was 4.05 0.7 mI/mm in hR versus 8.9 0.9 mi/mm in hR + anti-ET-1 antibody versus 10.8 0.3 ml/min in controls, P < 0.05 of hR with respect to the other two groups.
Discussion
The rationale for the present study was based on previous evidence that separately implicated ET-1 as a relevant mediator in renal hR [10, 11] and in neutrophil activation [18, 20] . The administration of the anti-ET-1-antibody revealed that ET-i was a crucial mediator not only of renal functional derangement but also of post-hR renal neutrophil accumulation. The specificity of this effect and the significant role of FT-i-related expression or neutrophil adhesive integrins were supported by the results obtained with the in vivo ET-1 infusions and flow cytometry isolated perfused kidneys experiments.
The accumulation of neutrophils after hR is a well characterized phenomenon in different organs [3, 7, 8, [33] [34] [35] . At the present time, the prevalent opinion indicates that neutrophils may have a role in aggravating the severity of myocardial and mesenteric ischemia [33] [34] [35] , but their pathogenetic potential in renal hR is still controversial. Data have been obtained that either deny [7, 36] or favor [8, 37] the importance of neutrophils in renal h/R, and the debate is still alive. Our experiments suggested that a significant neutrophil accumulation occurred in the kidney in the first hour after hR. This phenomenon was evidenced by the MPO method but not by the histological techniques. This apparent discordance between both methods therefore suggests that 60 minutes of hR might be too short a time to detect a significant increase in neutrophil infiltration in the microscopical preparations. Accordingly, in this setting MPO might be a more sensitive technique. Similar to our findings, Thornton et al observed no histological evidence of neutrophil infiltration after a 60-minute ischemic period [7] . Moreover, Solez, Kramer and Fox have found that a significant presence of leukocytes could not be demonstrated by histology up to 36 hours after experimental acute renal failure [25] . The validity of the MPO method in this case is supported by the specific and high concentration of MPO within the azurophil bodies of the granulocytes, which makes any other resident or macrophage type cell unlikely to be responsible for any increase in MPO activity. An explanation for this apparent dissociation between the histological and MPO findings can be derived from data recently published by Saeki et al [38] , who found that in conditions of neutrophil activation and massive degranulation, MPO is released outside the neutrophils and bounds to kidney cellular membranes. In these conditions, degranulated neutrophils would be not longer identified by histological techniques, whereas MPO activity would be readily quantified by enzymatic assays.
It is necessary to re-emphasize, however, that our experiments were not specifically aimed at analyzing the role of neutrophils in the outcome of renal hR. In fact, the present studies were circumscribed only to examine the role of ET-1 and the mechanisms intervening in neutrophil accumulation during renal hR. In this regard, three aspects appeared with a defined profile: (a) the same maneuver that interfered with the renal functional consequences of h/R, namely, the anti-ET-l antibody infusion, blocked neutrophil accumulation; (b) the specificity of this effect was demonstrated by several experimental findings, namely, the effect of the TSi/18 antibody in the in vitro perfusion experiments, the increase in CD18 expression by ET-1 detected in the flow cytometry studies and the lack of effect of the renal vasodilator, dopamine, in MPO levels. (c) ET-1 infusion per se favored the neutrophil accumulation in the kidneys, as we have previously observed in heart tissue [18] . The experiments showing that the anti-FT-I antibody blocked the post-hR neutrophil accumulation strongly suggested that ET-1 was a significant mediator of this phenomenon. The renal functional improvement observed in the same experiments further confirms that the anti-ET-1 antibody was effective in modifying the immediate outcome of renal h/R, even in the isolated perfused kidney. The findings on neutrophils adherence should, however, be mainly traced to an integrin- to be specifically addressed. In fact, these results suggest that myocardial effects may occur during ischemic episodes in distant organs. The possibility for the observed myocardial neutrophil accumulation to be pathologically relevant should be considered on the light of the proposed role of neutrophils on deranged myocardial function [39] . Preliminary data from Atanasova et al [40] have suggested that, in circumstances of NO-generation inhibition, renal hR may provoke systemic circulatory complications.
The present results expand to neutrophil-mediated effects the possible actions of ET-1 as a pathogenetic agent in early hR.
However, since increased release of FT-i can be expected as long as post-hR endothelial persists, this finding may provide a clue to understanding the pathophysiological sequence leading to sustained neutrophil accumulation and prolonged post-ischemic renal damage, and perhaps for neutrophil infiltration in pathological situations involving ET-1 release other than hR.
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